Article
Health Care Sciences & Services
Adam Lavertu, Tymor Hamamsy, Russ B. Altman
Summary: This study uses a novel semisupervised approach to estimate the severity of over 28,000 ADRs, with results showing good correlations with real-world outcomes. Additionally, the research identifies differences in severity distributions of ADRs and successfully generates quantitative drug-risk profile scores for nearly 1,000 drugs.
JOURNAL OF MEDICAL INTERNET RESEARCH
(2021)
Article
Pharmacology & Pharmacy
Monica Valdes-Garicano, Gina Mejia-Abril, Diana Campodonico, Raul Parra-Garces, Francisco Abad-Santos
Summary: This study evaluated the performance of a laboratory alerts system as a method for detecting adverse drug reactions (ADRs) using hyponatremia and rhabdomyolysis as case studies. The results showed that a pharmacovigilance program based on automatized laboratory signals could effectively detect ADRs, and the study of the hyponatremia laboratory alert was found to be more efficient than rhabdomyolysis.
FRONTIERS IN PHARMACOLOGY
(2022)
Review
Pharmacology & Pharmacy
Kristopher Amaro-Hosey, Immaculada Danes, Antonia Agusti
Summary: A systematic review revealed a high incidence of ADR in pediatric oncohematology patients, along with significant variability in study design and results. Enhancing methodological standards and preventability assessment is crucial for result comparison and identifying areas for improvement in future research.
FRONTIERS IN PHARMACOLOGY
(2022)
Article
Medicine, General & Internal
Daniel Gomes, Maria Teresa Herdeiro, Ines Ribeiro-Vaz, Pedro Lopes Ferreira, Fatima Roque
Summary: This study aimed to identify potentially inappropriate medications within adverse drug reactions reported in the Portuguese pharmacovigilance system. The findings highlight the importance of improving medication appropriateness in the older population to prevent serious adverse reactions and hospitalizations.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Medicine, General & Internal
Yan-zhong Han, Yu-ming Guo, Peng Xiong, Fei-lin Ge, Jing Jing, Ming Niu, Xu Zhao, Zhao-fang Bai, Hai-bo Song, Xiao-he Xiao, Jia-bo Wang
Summary: This study found that the aging population is more susceptible to liver-related ADRs, with the relative risk increasing exponentially with age. It is important to address risk management for older adults when using drugs with a high correlation to the risk of ADRs.
FRONTIERS IN MEDICINE
(2022)
Article
Oncology
Zhiming Jiao, Zhanchun Feng, Ziqi Yan, Jinwen Zhang, Gang Li, Ganyi Wang, Qianyu Wang, Da Feng
Summary: This study collected 431 ADR reports related to antineoplastic drugs in pediatric patients, finding that myelosuppression was the most frequent ADR. The median age of patients was six years, with higher reporting rates in the age group of 1-3 years. Three off-label ADRs were identified through signal mining, calling for further research and attention.
FRONTIERS IN ONCOLOGY
(2021)
Article
Health Care Sciences & Services
Agne Valinciute-Jankauskiene, Kubiliene Loreta
Summary: The study found that patients were able to identify ADRs and used different information sources about medicines and ADRs to confirm their beliefs. However, poor communication between consumers, pharmacists, and physicians is the main barrier to ADR reporting. This study identified the challenges in relation to pharmacovigilance in Lithuania from patients' perspectives, indicating a lack of clearly set standards and communication guidelines between patients, physicians, and pharmacists.
Review
Public, Environmental & Occupational Health
Joel Fossouo Tagne, Reginald Amin Yakob, Thu Ha Dang, Rachael Mcdonald, Nilmini Wickramasinghe
Summary: Despite existing national and international guidelines, there is significant variability in the standards of adverse drug reaction (ADR) reporting among healthcare facilities. There is room for improvement in ADR reporting rates among consumers and healthcare professionals. A thorough assessment of barriers and enablers to ADR reporting at the primary healthcare level is necessary, and interventions such as the black triangle scheme and GuildLink may benefit from further improvement and awareness programs.
JMIR PUBLIC HEALTH AND SURVEILLANCE
(2023)
Article
Pharmacology & Pharmacy
Kristopher Amaro-Hosey, Immaculada Danes, Lourdes Vendrell, Laura Alonso, Berta Renedo, Luis Gros, Xavier Vidal, Gloria Cereza, Antonia Agusti
Summary: This study found that adverse drug reactions (ADR) are common in pediatric oncohematological patients, mainly involving blood disorders and infections. Most ADR were dose-dependent or expected, and controversial additional prevention measures were identified.
FRONTIERS IN PHARMACOLOGY
(2021)
Article
Pharmacology & Pharmacy
Lara Magro, Elena Arzenton, Roberto Leone, Marilisa Giustina Stano, Michele Vezzaro, Annette Rudolph, Irene Castagna, Ugo Moretti
Summary: The study found that about one-third of patients exposed to potential drug-drug interactions actually experienced serious adverse drug reactions, and that a spontaneous reporting database can be used to identify and describe ADRs caused by drug-drug interactions. Among these ADRs, warfarin was the most frequently reported interacting drug and the most common ADRs were gastrointestinal or cerebral hemorrhagic events.
FRONTIERS IN PHARMACOLOGY
(2021)
Article
Health Care Sciences & Services
Jhih-Yuan Huang, Wei-Po Lee, King-Der Lee
Summary: Social forums provide new channels for constructing predictive models of adverse drug reactions (ADRs) for post-marketing surveillance. However, challenges still exist due to the characteristics of social posts. To address these issues, we performed data analytics from the perspectives of data balance, feature selection, and feature learning, and introduced a deep learning-based approach to enhance predictive performance.
Article
Dentistry, Oral Surgery & Medicine
Birita Sofia Ellefsen, Kristine Ron Larsen, Jesper Reibel, Camilla Kragelund
Summary: Post-marketing pharmacosurveillance is crucial for minimizing harm to patients from marketed drugs. Oral adverse drug reactions (OADRs) are underreported, and their inclusion in drug summary of product characteristics (SmPC) is limited. The reporting pattern of healthcare professionals is influenced by community debates, professional circles, and drug SmPC information. Systematic, reliable, and consistent reporting is essential to avoid skewed information and all healthcare professionals should be educated to recognize and report suspected adverse drug reactions.
Article
Geriatrics & Gerontology
Gianluca Sferrazza, Giuseppe Nicotera, Pasquale Pierimarchi
Summary: Elderly patients have higher reporting rates of ADRs compared to the general population, with a higher proportion of severe reports requiring hospitalization or long-term care, impacting national health service costs. The data suggest the need to optimize clinical strategies to enhance elderly patients' resilience to ADRs.
AGING CLINICAL AND EXPERIMENTAL RESEARCH
(2021)
Article
Pharmacology & Pharmacy
Louis Letinier, Amandine Ferreira, Alexandre Marceron, Marina Babin, Joelle Micallef, Ghada Miremont-Salame, Antoine Pariente
Summary: The study found that hemorrhage was the most common clinical manifestation of serious adverse drug reactions resulting from drug-drug interactions reported in France, followed by renal failure, pharmacokinetic alteration, and cardiac arrhythmias. More than one-third of serious adverse drug reactions involved at least three drugs.
FRONTIERS IN PHARMACOLOGY
(2021)
Article
Medicine, General & Internal
Laura Lopez-Valverde, Elia Domenech, Marc Roguera, Ignasi Gich, Magi Farre, Carlos Rodrigo, Eva Montane
Summary: The study analyzed spontaneously reported ADRs in pediatric patients between 2010 and 2020, finding that nervous system disorders were the most common type of ADR in pediatric patients, and medication errors were more frequent in patients under two years of age.
JOURNAL OF CLINICAL MEDICINE
(2021)
Review
Pharmacology & Pharmacy
Florence van Hunsel, Linda Harmark, Lean Rolfes
EXPERT OPINION ON DRUG SAFETY
(2019)
Article
Pharmacology & Pharmacy
Florence van Hunsel, Sonja van de Koppel, Souad Skalli, Andrea Kuemmerle, Lida Teng, Jia-bo Wang, Joanne Barnes
FRONTIERS IN PHARMACOLOGY
(2019)
Article
Pediatrics
Corine Ekhart, Tjalling de Vries, Florence van Hunsel
ARCHIVES OF DISEASE IN CHILDHOOD
(2020)
Article
Medicine, Research & Experimental
Pieter J. Glerum, Marc Maliepaard, Vincent de Valk, Joep H. G. Scholl, Florence P. A. M. van Hunsel, Eugene P. van Puijenbroek, David M. Burger, Kees Neef
CTS-CLINICAL AND TRANSLATIONAL SCIENCE
(2020)
Letter
Public, Environmental & Occupational Health
Lean Rolfes, Michelle Haaksman, Florence van Hunsel, Eugene van Puijenbroek
Article
Pharmacology & Pharmacy
Fatma Karapinar-Carkit, Patricia M. L. A. van den Bemt, Mariam Sadik, Brigit van Soest, Wilma Knol, Florence van Hunsel, Diana A. van Riet-Nales
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
(2020)
Article
Public, Environmental & Occupational Health
Linda Harmark, Gerda Weits, Rietje Meijer, Federica Santoro, G. Niklas Noren, Florence van Hunsel
Correction
Public, Environmental & Occupational Health
Linda Harmark, Gerda Weits, Rietje Meijer, Federica Santoro, G. Niklas Noren, Florence van Hunsel
Article
Public, Environmental & Occupational Health
Katherine Chinchilla, Cristiano Matos, Victoria Hall, Florence van Hunsel
Summary: This study aims to understand patient organizations' perceptions of pharmacovigilance, the barriers they face when implementing pharmacovigilance activities, and their interaction with other stakeholders. The results suggest that creating awareness campaigns, conducting more research, providing education, and improving communication are key strategies to stimulate patient organization participation and promote drug safety. Patient organizations are increasingly recognized as important stakeholders in pharmacovigilance, but still encounter internal and external barriers that hinder their full involvement.
Article
Obstetrics & Gynecology
Michael Ceulemans, Veerle Foulon, Elin Ngo, Alice Panchaud, Ursula Winterfeld, Leo Pomar, Valentine Lambelet, Brian Cleary, Fergal O'Shaughnessy, Anneke Passier, Jonathan L. Richardson, Titia Hompes, Hedvig Nordeng
Summary: This multinational study found high levels of depressive symptoms and generalized anxiety among pregnant and breastfeeding women during the COVID-19 outbreak. Risk factors associated with poor mental health included having a chronic mental illness, a chronic somatic illness in the postpartum period, smoking, having an unplanned pregnancy, professional status, and living in the UK or Ireland.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
(2021)
Article
Environmental Sciences
Michael Ceulemans, Veerle Foulon, Alice Panchaud, Ursula Winterfeld, Leo Pomar, Valentine Lambelet, Brian Cleary, Fergal O'Shaughnessy, Anneke Passier, Jonathan Luke Richardson, Karel Allegaert, Hedvig Nordeng
Summary: During the COVID-19 pandemic, pregnant and breastfeeding women showed hesitancy towards COVID-19 vaccines, with views influenced by education level and employment status. The pandemic had a negative impact on pregnancy experiences, access to healthcare, and breastfeeding support for many women.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
(2021)
Article
Environmental Sciences
Michael Ceulemans, Veerle Foulon, Alice Panchaud, Ursula Winterfeld, Leo Pomar, Valentine Lambelet, Brian Cleary, Fergal O'Shaughnessy, Anneke Passier, Jonathan Luke Richardson, Hedvig Nordeng
Summary: Insight into the epidemiology of perinatal medication use during the COVID-19 pandemic is scarce. A cross-sectional study conducted in five countries investigated the prevalence and type of medications used by pregnant and breastfeeding women during the first wave of the pandemic. The study found that perinatal medication use was highly prevalent, with the most commonly used medications belonging to the nervous system, respiratory system, alimentary tract/metabolism, and musculo-skeletal system categories. Factors such as chronic illness, country, maternal age, SARS-CoV-2 testing, professional status, and time since delivery were associated with medication use.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
(2022)
Article
Environmental Sciences
Eva Gerbier, Guillaume Favre, Fatima Tauqeer, Ursula Winterfeld, Milos Stojanov, Alison Oliver, Anneke Passier, Hedvig Nordeng, Leo Pomar, David Baud, Alice Panchaud, Carla Meyer-Massetti, Michael Ceulemans
Summary: Information on medication utilization among pregnant and postpartum women during the pandemic is lacking. This study investigated the prevalence and patterns of medication use among this population during the third wave of the pandemic. The results showed that the medication use patterns were mostly similar to those of the first wave and the pre-pandemic period, with lower prevalence of anti-infectives.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
(2022)
Article
Pharmacology & Pharmacy
Cristiano Matos, Florence van Hunsel, Rogerio Tavares Ribeiro, Nascimento O. Do Dulce, Joao Filipe Raposo
THERAPEUTIC ADVANCES IN DRUG SAFETY
(2020)
Article
Chemistry, Medicinal
Misha F. Vrolijk, Geja J. Hageman, Sonja van de Koppel, Florence van Hunsel, Aalt Bast